Delivery Order SPE2DB24D1007-SPE2DB25FCAUP
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,044.76, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order that has a completion date of January 28, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,088.36, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 11, 2025. This award is not designated as a set-aside. The contract is associated with a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.00, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 11, 2024. This award is not designated as a set-aside contract. AmerisourceBergen maintains a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication. The award has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is a delivery order for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 27, 2024. The award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 27, 2025. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,360.45, is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 20, 2025. The contract has no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,360.45 and a completion date of March 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,360.45, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract...